Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
Abstract
Background
Ghrelin and zinc finger BED domain-containing protein 3 (ZBED3) are distinctively cross linked with prediabetes (preDM) and metabolic syndrome (MetS).
Materials and methods
In a cross-sectional design with 29 normoglycemic MetS and 30 newly diagnosed drug naïve preDM/MetS patients vs. 29 lean and normoglycemic controls; ghrelin and ZBED3 were evaluated using colorimetric enzymatic assays.
Results
While ZBED3 mean circulating levels (ng/mL) in both MetS groups (normoglycemic and preDM) invariably lacked discrepancy vs. controls; Appreciably ghrelin levels (ng/mL) in preDM/MetS (but not normoglycemic MetS) participants were markedly higher vs. controls. Except for fasting plasma glucose (FPG) and glycosylated-hemoglobin (HbA1C); no further intergroup discrepancy could be identified between the MetS arms. Remarkably adiposity indices (body mass index (BMI), body adiposity index (BAI), and lipid accumulation product (LAP), but not conicity index (CI) or visceral adiposity index (VAI)); atherogenicity index of plasma (but not non-high-density lipoprotein-cholesterol (non-HDL-C/HDL-C) ratio, or total cholesterol (TC)/HDL-C ratio) or any of hematological indices (red cell distribution width (RDW-CV%), monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR) and platelet (PLT) to lymphocyte ratio (PLR)) were substantially higher in both MetS (non- and preDM) groups vs. those of controls. Exceptionally low-density lipoprotein -cholesterol (LDL-C)/HDL-C ratio, and waist circumference (WC)/hip circumference (HC) ratio were much more pronounced in MetS-preDM vs. normoglycemic MetS recruits. In the MetS pool (both normoglycemic and preDM, n = 58), neither biomarker could relate to each other, or any of clinical parameters, adiposity or atherogenecity indices. Exceptionally ghrelin correlated significantly and inversely with age. ZBED3 correlated significantly and directly with RDW-CV% in the same pool of MetS recruits (n = 59).
Conclusions
Both biomarkers can not be ruled out as putative predictive/surrogate prognostic tools for metabolic anomalies prevention and pharmacotherapy.
Acknowledgment
Authors are thankful for The Deanship of Academic Research and Quality Assurance/The University of Jordan for supporting this research.
Author Statement
Research funding: Authors state no funding was involved.
Conflict of interest: The authors declare none.
Informed consent: Informed consent has been obtained from the participants.
Ethical approval: The study was approved by the (IRB) committee of the University of Jordan Hospital and from the Scientific Research Committee at the School of Pharmacy.
References
[1] Collden G, Tschop MH, Muller TD. Therapeutic potential of targeting the ghrelin pathway. Int J Mol Sci. 2017;18:1–29.10.3390/ijms18040798Suche in Google Scholar PubMed PubMed Central
[2] Gandhi M, Swaminathan S. Ghrelin and obesity-an update. Int J Pharm Clin Res. 2017;9:51–4.Suche in Google Scholar
[3] Gavrieli A, Mantzoros CS. Novel molecules regulating energy homeostasis: physiology and regulation by macronutrient intake and weight loss. Endocrinol Metab. 2016;31:361–72.10.3803/EnM.2016.31.3.361Suche in Google Scholar PubMed PubMed Central
[4] Pulkkinen L, Ukkola O, Kolehmainen M, Uusitupa M. Ghrelin in diabetes and metabolic syndrome. Int J Pept. 2010;2010:1–11.10.1155/2010/248948Suche in Google Scholar PubMed PubMed Central
[5] Chabot F, Caron A, Laplante M, St-Pierre DH. Interrelationships between ghrelin, insulin and glucose homeostasis: physiological relevance. World J Diabetes. 2014;5:328–41.10.4239/wjd.v5.i3.328Suche in Google Scholar PubMed PubMed Central
[6] Lewitt MS. Effect of ghrelin on hepatic IGF-binding protein-1 production. ISRN Obesity. 2013;2013:751401.10.1155/2013/751401Suche in Google Scholar PubMed PubMed Central
[7] Mani BK, Zigman JM. Ghrelin as a survival hormone. Trends Endocrinol Metab. 2017;28:P843–54.10.1016/j.tem.2017.10.001Suche in Google Scholar PubMed PubMed Central
[8] Ou F, Su K, Sun J, Liao W, Yao Y, Zheng Y, et al. The LncRNA ZBED3-AS1 induces chondrogenesis of human synovial fluid mesenchymal stem cells. Biochem Biophys Res Commun. 2017;487:457–63.10.1016/j.bbrc.2017.04.090Suche in Google Scholar PubMed
[9] Jia Y, Yuan L, Hu WY, Luo L, Suo M, Yang S, et al. Zinc‐finger BED domain‐containing 3 (Zbed3) is a novel secreted protein associated with insulin resistance in humans. J Intern Med. 2014;275:522–33.10.1111/joim.12170Suche in Google Scholar PubMed
[10] Hu W, Tian B, Li X, Li L, Zhang L, Liu H, et al. Circulating zbed3 levels in subjects with and without metabolic syndrome. Metab Syndr Relat Disord. 2017;15:207–12.10.1089/met.2016.0122Suche in Google Scholar PubMed
[11] Peng S, Cao L, He S, Zhong Y, Ma H, Zhang Y, et al. An Overview of Long Noncoding RNAs involved in bone regeneration from mesenchymal stem cells. Stem Cells Int. 2018;2018:8273648.10.1155/2018/8273648Suche in Google Scholar PubMed PubMed Central
[12] Tonding SF, Silva FM, Antonio JP, Azevedo MJ, Canani LH, and Almeida JC. Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. Nutr J. 2014;13:1–7.10.1186/1475-2891-13-124Suche in Google Scholar PubMed PubMed Central
[13] Kavaric N, Klisic A, Ninic A. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2018;32:1–9.10.1002/jcla.22283Suche in Google Scholar PubMed PubMed Central
[14] Edwards MK, Blaha MJ, Loprinzi PD. Influence of sedentary behavior, physical activity, and cardiorespiratory fitness on the atherogenic index of plasma. J Clin Lipidol. 2017;11:119–25.10.1016/j.jacl.2016.10.014Suche in Google Scholar PubMed
[15] Xanthopoulos A, Giamouzis G, Melidonis A, Kitai T, Paraskevopoulo E, Paraskevopoulou P, et al. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol. 2017;16:1–9.10.1186/s12933-017-0563-1Suche in Google Scholar PubMed PubMed Central
[16] Sharifi F, Yamini M, Esmaeilzade A, Mousavinasab N, Shajari Z. Acylated ghrelin and leptin concentrations in patients with type 2 diabetes mellitus, people with prediabetes and first degree relatives of patients with diabetes, a comparative study. J Diabetes Metab Disord. 2013;12:1–6.10.1186/2251-6581-12-51Suche in Google Scholar PubMed PubMed Central
[17] Mohamed SW, Hassanien AM, Sayed Abokhosheim ELK. Role of ghrelin, leptin and insulin resistance in development of metabolic syndrome in obese patients. Endocrinol Metab Syndr. 2014;3:1–6.10.4172/2161-1017.1000122Suche in Google Scholar
Supplementary Material
The online version of this article offers supplementary material (DOI: https://doi.org/10.1515/hmbci-2018-0052).
©2019 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Original Articles
- The effects of estradiol and testosterone on renal tissues oxidative after central injection of angiotensin II in female doca – salt treated rats
- Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes
- Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
- Copper and zinc in stage I multiple myeloma: relation with ceruloplasmin, lipid peroxidation, and superoxide dismutase activity
- Short Communication
- Ovarian reserve in adolescent girls born prematurely
Artikel in diesem Heft
- Original Articles
- The effects of estradiol and testosterone on renal tissues oxidative after central injection of angiotensin II in female doca – salt treated rats
- Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes
- Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
- Copper and zinc in stage I multiple myeloma: relation with ceruloplasmin, lipid peroxidation, and superoxide dismutase activity
- Short Communication
- Ovarian reserve in adolescent girls born prematurely